Real-world data on change in work productivity, activity impairment, and quality of life in patients with psoriatic arthritis under anti-TNF therapy: a postmarketing, noninterventional, observational study.
Ömer KaradağEdiz DalkilicGizem AyanOrhan KucuksahinTimucin KasifogluNeslihan YilmazSuleyman Serdar KocaVeli YazisizPinar Talu ErtenMehmet SayarliogluMustafa Ender TerziogluSukran ErtenUmut KalyoncuPublished in: Clinical rheumatology (2021)
NCT02028169 Key Points • Psoriatic arthritis (PsA), with debilitating effects on quality of life, occurs mostly in young adults and has negative impacts on employment status and work productivity. • Early PsA diagnosis and treat-to-target treatment strategies aim to reduce pain and joint damage, as well as improve work productivity. • Real-world data on the impact of treatment with anti-tumor necrosis factor (anti-TNF) agents on work productivity in PsA in the literature is scarce. • Our study of real-world data in patients with PsA receiving anti-TNF treatment showed improvement in work productivity, as well as in clinical and patient-reported outcomes.
Keyphrases
- prostate cancer
- climate change
- rheumatoid arthritis
- patient reported outcomes
- young adults
- electronic health record
- radical prostatectomy
- big data
- systematic review
- chronic pain
- oxidative stress
- stem cells
- spinal cord injury
- neuropathic pain
- mental health
- pain management
- combination therapy
- cell therapy
- replacement therapy
- postoperative pain